Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,789 | -30,341 | -15,854 | -52,975 | -37,283 |
| Depreciation Amortization | 539 | 747 | 456 | 1,640 | 643 |
| Accounts payable and accrued liabilities | 1,157 | -145 | 1,724 | -28 | -1,055 |
| Other Working Capital | -553 | -1,101 | -142 | -4,299 | -2,928 |
| Other Operating Activity | 8,545 | 6,343 | 1,208 | 9,282 | 6,374 |
| Operating Cash Flow | $-37,101 | $-24,497 | $-12,608 | $-46,380 | $-34,249 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -502 | -437 | -380 | -2,453 | -2,137 |
| Purchase Of Investment | -23,085 | -23,085 | 25,000 | -24,764 | -24,764 |
| Investing Cash Flow | $-23,587 | $-23,522 | $24,620 | $-27,217 | $-26,901 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94,582 | 94,484 | 226 | 32,982 | 91 |
| Financing Cash Flow | $94,582 | $94,484 | $226 | $32,982 | $91 |
| Beginning Cash Position | 81,607 | 81,607 | 81,607 | 122,222 | 122,222 |
| End Cash Position | 115,501 | 128,072 | 93,845 | 81,607 | 61,163 |
| Net Cash Flow | $33,894 | $46,465 | $12,238 | $-40,615 | $-61,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,101 | -24,497 | -12,608 | -46,380 | -34,249 |
| Capital Expenditure | -502 | -437 | -380 | -2,453 | -2,137 |
| Free Cash Flow | -37,603 | -24,934 | -12,988 | -48,833 | -36,386 |